Development of the First Russian Gene Therapy Drug for Hemophilia B is Underway in Russia
In most participants of clinical trials, the activity of blood coagulation factor IX increased
NMIC gematologii Minzdrava
In most participants of clinical trials, the activity of blood coagulation factor IX increased